Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The anxiety and depression treatment market was valued at USD 12.18 Billion in 2024, driven by the rising prevalence of mental health disorders across the 8 major markets. The market is anticipated to grow at a CAGR of 3.10% during the forecast period of 2025-2034 to achieve a value of USD 16.53 Billion by 2034. The growing awareness and acceptance of mental health conditions are driving increased demand for innovative treatments for anxiety and depression.

2024

Base Year

2018-2024

Historical Period

2025-2034

Forecast Period

  • The rising awareness and acceptance of mental health issues are increasing demand for innovative anxiety and depression treatments.

  • Technological advancements like brain stimulation devices are expected to revolutionize non-pharmacological treatment approaches for mental health.

  • Pharmaceutical innovations and FDA approvals for novel antidepressants are accelerating market growth and expanding therapeutic options for patients.

Compound Annual Growth Rate

3.1%

Value in USD Billion

2025-2034


Anxiety and Depression Treatment Market Outlook

*this image is indicative*

Anxiety and Depression Treatment Market Overview

Anxiety and depression are common mental health disorders characterized by persistent worry, fear, sadness, and loss of interest. These conditions can affect mood, behavior, and daily functioning. According to the World Health Organization (WHO), an estimated 3.8% of the global population experiences depression, including 5% of adults—4% of men and 6% of women—and 5.7% of individuals over the age of 60. Treatment typically includes a combination of antidepressant medications such as SSRIs or SNRIs, therapy like Cognitive Behavioral Therapy (CBT), and emerging technologies like brain stimulation devices. The market is anticipated to grow at a CAGR of 3.10% during the forecast period of 2025-2034. Early diagnosis and personalized treatment plans are essential for effective symptom management and improved quality of life.  

Anxiety and Depression Treatment Market Growth Drivers

Innovative Therapies and Rising Mental Health Awareness Driving Market Growth

The growing prevalence of treatment-resistant depression and the urgent need for effective therapies are key drivers of the anxiety and depression treatment market. For instance, in January  2025, Johnson & Johnson secured FDA approval for SPRAVATO® (esketamine) nasal spray as the first monotherapy for adults with major depressive disorder who do not respond to at least two oral antidepressants. This approval addresses a significant unmet need, enhancing treatment options and is expected to accelerate market expansion during the forecast period.

Rise in Clinical Trial Initiatives to Meet Rising Anxiety and Depression Treatment Market Demand

Increasing focus on novel drug delivery methods and better understanding of social anxiety disorder (SAD) epidemiology are important market drivers. For instance, in April  2025, Vistagen presented new data on SAD and age of onset from its Phase 3 program at the Anxiety and Depression Association of America Conference. This research strengthens knowledge of SAD prevalence in young adults, supporting the development of innovative intranasal treatments that could expand therapeutic options and stimulate growth in the anxiety and depression treatment market over the forecast period.

Anxiety and Depression Treatment Market Trends

Anxiety and Depression Treatment Market Segmentation

Anxiety and Depression Treatment Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Treatment Type

  • Antidepressant Drugs 
    • Selective Serotonin Reuptake Inhibitors (SSRIs) 
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) 
    • Tricyclic Antidepressants (TCAs) 
    • Monoamine Oxidase inhibitors (MAOIs) 
    • Atypical Antipsychotics 
    • Benzodiazepines 
    • Anticonvulsants 
    • Beta-Blockers 
    • Others
  • Therapy and Devices 
    • Fisher-Wallace Stimulator  
    • Transcranial Magnetic Stimulation (TMS)  
    • Deep Brain Stimulation (DBS)  
    • Vagus nerve stimulation (VNS)  
    • Electroconvulsive Therapy (ECT)  
    • Cognitive Behaviour Therapy (CBT)  
    • Others

Market Breakup by Indication

  • Major Depressive Disorder (MDD) 
  • Obsessive-Compulsive Disorder (OCD) 
  • Phobia 
  • Others

Market Breakup by Age Group

  • Adult
  • Geriatric 
  • Pediatric

Market Breakup by Distribution Channel

  • Hospital Pharmacy 
  • Retail Pharmacy 
  • Online Channels 
  • Others

Market Breakup by Region

  • United States 
  • United Kingdom 
  • Germany 
  • France 
  • Italy 
  • Spain 
  • Japan 
  • India

Anxiety and Depression Treatment Market Share

Selective Serotonin Reuptake Inhibitors (SSRIs) to Lead the Segmentation by Treatment Type

Selective serotonin reuptake inhibitors (SSRIs) are expected to hold the largest share in the market due to their proven efficacy, minimal side effects, and first-line use in clinical guidelines. As more individuals are diagnosed early and seek medical help, SSRIs remain the preferred initial pharmacological intervention. Their availability in generics, growing awareness, and rising healthcare access make SSRIs the most prescribed and widely accepted treatment option, thus driving long-term market expansion during the forecast period.

Major Depressive Disorder (MDD) to Hold a Substantial Anxiety and Depression Treatment Market Value by Indication

Major depressive disorder (MDD) is anticipated to dominate the indication segment due to its high global prevalence and increasing diagnosis rates. The World Health Organization reports that globally, around 280 million people are affected by depression. The condition is approximately 50% more prevalent in women than in men. Additionally, over 10% of pregnant women and new mothers suffer from depression. Each year, more than 700,000 people die by suicide, making it the fourth leading cause of death among individuals aged 15 to 29. Innovations in treatment-resistant depression therapies and growing public awareness have fueled demand. As clinical focus sharpens on personalized and early interventions, MDD remains a central area for treatment development, positioning it to lead the market throughout the forecast period.

Anxiety and Depression Treatment Market Analysis by Region

The United States is expected to dominate the market due to its leadership in neurotechnology innovation and early regulatory approvals. For instance, in March  2025, the FDA granted breakthrough device designation to a novel non-invasive brain stimulation system developed by Pulvinar Neuro for treating psychiatric disorders. With strong R&D backing and rapid clinical adoption, the United States continues to outpace Europe and Asia in translating neuroscience breakthroughs into commercial treatments, solidifying its market leadership.

Leading Players in the Anxiety and Depression Treatment Market

The key features of the market report comprise patent analysis, grants analysis, clinical trial analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Pfizer Inc.

Headquartered in New York City and founded in 1849, Pfizer Inc. is a global pharmaceutical giant known for developing innovative therapies across various therapeutic areas. In the mental health segment, Pfizer’s portfolio includes antidepressants and anti-anxiety medications, notably Zoloft and Effexor XR. The company continues to invest in neuroscience research to expand its footprint in psychiatric treatment.

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK), based in Brentford, United Kingdom, was established in 2000 following the merger of Glaxo Wellcome and SmithKline Beecham. GSK’s neuroscience portfolio includes medications for depression and anxiety such as Paxil and Lamictal. The company also supports mental health treatment access initiatives in low-income countries, furthering its role in the global psychiatric drug market.

AstraZeneca plc

Founded in 1999 and headquartered in Cambridge, United Kingdom, AstraZeneca plc is a multinational pharmaceutical company with a presence in mental health through products like Seroquel, used for mood disorders. While it has shifted focus to oncology and cardiovascular areas, AstraZeneca’s historical role in psychiatric treatment continues to influence market trends and generic development.

Eli Lilly and Co.

Established in 1876 and headquartered in Indianapolis, Indiana, Eli Lilly and Co. is a prominent player in mental health pharmaceuticals. Its widely used antidepressants and antipsychotic drugs, including Prozac, Cymbalta, and Zyprexa, have set benchmarks in depression and anxiety treatment. The company remains committed to neuroscience innovation through ongoing research and clinical development.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Sanofi SA, Johnson & Johnson Innovative Medicine, AbbVie Inc., Viatris Inc., Abbott Laboratories, Teva Pharmaceutical Industries Ltd., and Apotex Corporation. 

Key Questions Answered in the Anxiety and Depression Treatment Market

  • What was the anxiety and depression treatment market value in 2024? 
  • What is the anxiety and depression treatment market forecast outlook for 2025-2034?
  • What are the major factors aiding the anxiety and depression treatment market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major anxiety and depression treatment market trends?
  • Which treatment type will lead the market segment?  
  • Which indication will lead the market segment?  
  • Which distribution channel will lead the market segment? 
  • Who are the key players involved in the anxiety and depression treatment market? 
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2024
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Indication
  • Age Group
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Antidepressant Drugs
  • Therapy and Devices
Breakup by Indication
  • Major Depressive Disorder (MDD) 
  • Obsessive-Compulsive Disorder (OCD) 
  • Phobia 
  • Others
Breakup by Age Group
  • Adult
  • Geriatric
  • Pediatric
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channels
  • Others
Breakup by Region
  • United States
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Japan
  • India
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Astrazeneca plc
  • Eli Lily and Co.
  • Sanofi SA
  • Johnson & Johnson Innovative Medicine
  • Abbvie Inc.
  • Viatris Inc.
  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd.
  • Apotex Corporation

Single User License

10 % Off

USD

5,499

4,949

Datasheet

10 % Off

USD

3,299

2,969

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us